Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

Hong Kong scientists develop probiotic formula to help combat COVID-19
Hong Kong scientists develop probiotic formula to help combat COVID-19
HONG KONG, June 13 (Xinhua) -- A probiotic formula was developed by scientists from the Chinese University of Hong Kong as a new approach to combat COVID-19, the university announced on Thursd...
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up and obtain regulatory approval for marketing of this drug in respect...
US approves first dispersible tablet formulation of Tivicay
US approves first dispersible tablet formulation of Tivicay
The US Food and Drug Administration has approved the first-ever dispersible tablet formulation of ViiV Healthcare's Tivicay (dolutegravir), used in combination with other antiretrovirals t...
EU regulators agree to review LEO's dermatitis drug
EU regulators agree to review LEO's dermatitis drug
EU regulators have accepted for review LEO Pharma's tralokinumab for the treatment of moderate-to-severe atopic dermatitis.
Takeda, debt in mind, offloads 18 drugs in Asia Pacific to Celltrion for $278M
Takeda, debt in mind, offloads 18 drugs in Asia Pacific to Celltrion for $278M
Takeda has earmarked another chunk of business for divestment to help it pay down debt.
FDA Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord
FDA Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord
The U.
COVID-19 may trigger new diabetes, experts warn
COVID-19 may trigger new diabetes, experts warn
Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people and also cause severe complications of pre-existing diabetes.
NICE rejects Sanofi's Cablivi in draft guidelines
NICE rejects Sanofi's Cablivi in draft guidelines
NICE has drawn up draft guidelines rejecting Sanofi's Cablivi (caplacizumab) for use alongside plasma exchange and immunosuppression for treating an acute episode of acquired thrombotic th...
Shiny new startup Egle grabs a deal with Takeda for cancer research
Shiny new startup Egle grabs a deal with Takeda for cancer research
It only officially launched in early 2020 but Egle Therapeutics is not hanging around, penning a new R&D deal with Japanese pharma Takeda.
Novo Nordisk bets $725M on heart-focused Corvidia—with the promise of $1.4B more
Novo Nordisk bets $725M on heart-focused Corvidia—with the promise of $1.4B more
Novo Nordisk plunked down $725 million for France’s Corvidia Therapeutics and its lead program, an anti-IL-6 antibody for the treatment of heart disease related to kidney disease.
COVID-19 vaccine from China's Sinopharm clears animal tests
COVID-19 vaccine from China's Sinopharm clears animal tests
China has five COVID-19 vaccines in clinical trials.
Regeneron sees ‘a lot of reason for hope’ as human testing of its coronavirus drug begins
Regeneron sees ‘a lot of reason for hope’ as human testing of its coronavirus drug begins
Regeneron Pharmaceuticals announced Thursday that it’s started the first clinical trial of its experimental coronavirus antibody drug.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand